NOVOERG OY - innovation research medical and pharmaceutical company from Finland.

Novoerg providing medical services for patients with drug and alcohol dependence from Finland and other countries of the European Union (in particular – long acting sustained release naltrexone formulations) through the leading psychiatric institutions in Russia.

Novoerg is currently developing a novel effective medication for alcohol dependence: Slow release long-acting formulation of aversive medication for alcoholism (LAAMFA).

Novoerg also establishes partnerships with government institutions, venture capitalists, angel  investors, pharmaceutical development companies,  and other investment institutions in the healthcare industry